A26c2 Inhibitors are a class of chemical compounds specifically designed to target the A26c2 protein, a molecular component involved in a variety of cellular mechanisms, particularly those related to signal transduction and molecular recognition. These inhibitors function by binding to critical regions of the A26c2 protein, disrupting its normal conformation or its ability to interact with other cellular molecules. The interaction between A26c2 Inhibitors and the protein is typically highly specific, often involving the inhibitor fitting precisely into a particular binding pocket or allosteric site on the protein. This precise binding can lead to a change in the protein's structure, rendering it inactive or unable to participate in its usual biological functions. The specificity of these inhibitors is typically achieved through careful molecular design, where the chemical structure of the inhibitor is tailored to match the unique features of the A26c2 protein.
The chemical properties of A26c2 Inhibitors, such as molecular size, shape, solubility, and stability, are essential for their effectiveness in interacting with the A26c2 protein. These inhibitors are often composed of both hydrophobic and hydrophilic regions, allowing them to engage in multiple types of interactions with the protein, including van der Waals forces, hydrogen bonds, and ionic interactions. The presence of aromatic rings, polar groups, or other functional moieties within the inhibitor's structure can further enhance its binding affinity and specificity. Additionally, the kinetics of inhibitor binding, including how rapidly the inhibitor associates with and dissociates from the A26c2 protein, are critical factors that influence the overall impact of the inhibitor. By binding to the A26c2 protein, these inhibitors can effectively modulate its activity, offering insights into the molecular dynamics of signal transduction and protein-protein interactions within the cell. Understanding the detailed interactions between A26c2 Inhibitors and their target protein is crucial for elucidating the broader role of A26c2 in cellular function and regulation.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Alizarin | 72-48-0 | sc-214519 sc-214519A | 1.5 g 100 g | $21.00 $51.00 | ||
Alizarin inhibits the enzymatic activity of metalloproteins, which could lead to the inhibition of ANKRD26-like family C, member 2 by disrupting its metal ion-dependent structural conformation. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein inhibits tyrosine kinases, potentially leading to the inhibition of ANKRD26-like family C, member 2 by preventing its phosphorylation and subsequent activation. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine inhibits a broad range of protein kinases, thereby possibly inhibiting ANKRD26-like family C, member 2 through suppression of kinase-mediated activation pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 inhibits PI3K, which could lead to inhibition of ANKRD26-like family C, member 2 by disrupting PI3K-dependent signaling pathways necessary for its activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin inhibits PI3K activity, which is crucial for certain signaling pathways, thereby potentially inhibiting ANKRD26-like family C, member 2 by preventing its activation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which could lead to inhibition of ANKRD26-like family C, member 2 by disrupting mTOR signaling pathways that may regulate its function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 inhibits MEK activity, potentially leading to inhibition of ANKRD26-like family C, member 2 by blocking the MAPK/ERK pathway and its downstream effects on the protein. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 inhibits MEK, potentially leading to inhibition of ANKRD26-like family C, member 2 by interrupting the MAPK/ERK signaling pathway involved in its activation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 inhibits p38 MAP kinase, potentially leading to the inhibition of ANKRD26-like family C, member 2 by blocking the p38 MAPK signaling pathways involved in its regulation. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits JNK, which could lead to the inhibition of ANKRD26-like family C, member 2 by interfering with JNK signaling pathways relevant to its activity. | ||||||